Randomized controlled trial assessing the effectiveness of midazolam premedication as an anxiolytic, analgesic, sedative, and hemodynamic stabilizer
Authors:
Open Access
- 1 August 2018
- journal article
- research article
- Published by Wolters Kluwer Health in Medicine
- Vol. 97 (35) , e12187
Abstract
Midazolam premedication is widely used before general anesthesia, but lacks clinical evidence of effectiveness. The present study aimed to evaluate the effectiveness of midazolam premedication following 4 aspects: anxiety reduction, sedation, hemodynamic stabilization, and analgesia. In a randomized, single-blind, prospective study, a total of 128 women were allocated to the midazolam premedication group (Group P, n = 64) or the control group (Group N, n = 64). The patients were asked to complete the Beck anxiety inventory (BAI) 2 times: on the day before surgery (BS) and 30 minutes after midazolam premedication (T0). Depth of anesthesia using state entropy (SE), conventional hemodynamic data using heart rate (HR) and mean blood pressure (MBP), and analgesic profiles using surgical pleth index (SPI) were acquired at the following 4 points: T1—pre-induction, T2—prior to intubation, T3—intubation, and T4—20 minutes after intubation. No change in BAI score was observed between BS and T0 in both groups P and N (median and interquartile range [IQR], Group P: BS—4.5 [2.0–7.0], T0—4.0 [1.0–9.0], P = .603; Group N: BS—4.0 [1.0–8.5], T0—3.5 [1.0–6.0], P = .066). Midazolam premedication reduced SE at T2–4 (mean difference with 95% confidence interval [95% CI], T2—7.1 [1.6–12.6], P = .012; T3—10.4 [6.5–14.4], P < .001; T4—9.2 [5.0–13.4], P < .001). Midazolam premedication also reduced HR (mean differences [95% CI], T1—7.3 [2.5–12.1], P = .003; T3—6.6 [1.1–12.2], P = .020) and MBP at T1 and T3 (mean differences [95% CI], T1—7.3 [2.5–12.1], P = .003; T3—8.6 [1.3–15.9], P = .021), and lowered SPI at T1–3 (mean differences [95% CI]: T1—12.7 [6.1–19.4], P < .001; T2—6.0 [0.5–11.5], P = .033; T3—7.9 [1.7–14.1], P = .012). Midazolam premedication did not reduce the level of anxiety. However, midazolam premedication reduced the entropy values, stabilized hemodynamics, and provided analgesia during the induction of anesthesia. The purpose of midazolam premedication needs to be reconsidered.Keywords
This publication has 32 references indexed in Scilit:
- The impact of depression and anxiety on self-assessed pain, disability, and quality of life in patients scheduled for rotator cuff repairJournal of Shoulder and Elbow Surgery, 2013
- Comparison of dexmedetomidine and three different doses of midazolam in preoperative sedationJournal of Anaesthesiology Clinical Pharmacology, 2011
- Availability of preoperative anxiety scale as a predictive factor for hemodynamic changes during induction of anesthesiaKorean Journal of Anesthesiology, 2010
- Preoperative intravenous midazolam: benefits beyond anxiolysisJournal of Clinical Anesthesia, 2004
- Oral midazolam premedication for day case breast surgery, a randomised prospective double-blind placebo-controlled studyAnaesthesia, 2001
- The Comparative Dose-Response Effects of Melatonin and Midazolam for Premedication of Adult Patients: A Double-Blinded, Placebo-Controlled StudyAnesthesia & Analgesia, 2000
- Premedication in the United StatesAnesthesia & Analgesia, 1997
- Premedication in the United StatesAnesthesia & Analgesia, 1997
- A power primer.Psychological Bulletin, 1992
- The relationship between anxiety and depressionClinical Psychology Review, 1985